Medical Journals

Neonatal Citalopram Exposure Produces Lasting Changes in Behavior Which Are Reversed by Adult Imipramine Treatment.

Authors:
  • Maciag Dorota
  • Williams Lashondra
  • Coppinger David
  • Paul Ian A

From: Department of Psychiatry & Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA.

European journal of pharmacology

  • Publish Date: Feb 2006
  • ISSN: 0014-2999
  • Volume: 532
  • Issue: 3
  • Pages: 265-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Maciag Dorota, Williams Lashondra, Coppinger David, et al. Neonatal Citalopram Exposure Produces Lasting Changes in Behavior Which Are Reversed by Adult Imipramine Treatment.. Eur. J. Pharmacol. Feb 2006;532:265-9

Abstract

Neonatal exposure to antidepressants, including selective serotonin reuptake inhibitors such as citalopram, induces behavioral disturbances which persist in mature rats. These disturbances have been proposed to model the symptoms of endogenous depression. However, to date there is scant evidence for the predictive validity of any of these behaviors in response to adult antidepressant treatments. In order to directly assess the predictive validity of the early antidepressant exposure paradigm, the present study examined whether the behavioral abnormalities observed in adult animals exposed as neonates to citalopram can be reversed by adult antidepressant treatment with the prototypic antidepressant, imipramine. As noted earlier, neonatal citalopram exposure robustly increased locomotor activity and impaired male sexual behavior in adult rats. These behavioral changes were reversed following chronic adult imipramine treatment. No such reversal was observed in handled, saline treated rats. The present data support the hypothesis that some of the lasting behavioral abnormalities induced by early antidepressant exposure are sensitive to clinically relevant antidepressant treatments thus adding a measure of predictive validity to this paradigm as a model of these depressive symptoms.

Mesh Headings (Keywords): Adrenergic Uptake Inhibitors, Animals, Animals, Newborn, Antidepressive Agents, Tricyclic, Behavior, Animal, Citalopram, Depression, Disease Models, Animal, Drug Evaluation, Preclinical, Imipramine, Male, Motor Activity, Rats, Rats, Long-Evans, Reproducibility of Results, Sexual Behavior, Animal


Check for Full Text / PubMed Unique Identifier (PMID): 16483567


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.